Dynamic circulating tumor cell profiling of biliary tract cancer patients receiving systemic therapy

Background Biliary tract cancers (BTCs) represent a heterogeneous and aggressive group of malignancies that arise from the biliary epithelial tree. The BTC metastatic state remains a very refractory state, and circulating tumor cells (CTC) can offer a window into the metastatic cascade. We applied a profiling method to understand CTC dynamics for patients with advanced stage BTCs receiving systemic therapy. Methods This was a prospective pilot study that included 15 patients with unresectable or metastatic BTCs receiving systemic therapy. CTCs were purified using a commercially available size-based method and enumerated using immunofluorescent staining for epithelial markers. CTC dynamics were benchmarked against conventional blood biomarkers and correlated with survival outcomes. Results We detected CTCs in every patient sample. CTC quantities did not decline during the early on-treatment time point and were correlated weakly with serum carbohydrate antigen 19–9 level and circulating tumor DNA median variant allele frequency. There was no significant correlation between baseline CTC quantities and progression-free or overall survival. Conclusions Our novel workflow, utilizing a commercially available CTC purification and enumeration process, enabled a sensitive method to quantitatively and serially monitor CTC abundance in a pilot study of patients with BTCs. Future studies will expand upon numbers of participants and the means to detect and characterize these rare metastatic precursor cells in patients with BTCs.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-18
DOI
https://doi.org/10.3389/fonc.2026.1959420
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dynamic circulating tumor cell profiling of biliary tract cancer patients receiving systemic therapy

Lauren Jung, Joseph Wang Franses, Aurelie Desgardin, Marcos Santiago Figueroa et al.
1 links
Frontiers in Oncology
Cholangiocarcinoma and Gallbladder Cancer Studies
article

Dynamic circulating tumor cell profiling of biliary tract cancer patients receiving systemic therapy

Lauren Jung, Joseph Wang Franses, Aurelie Desgardin, Marcos Santiago Figueroa, Anjana A Pillai, Chetan Nambiar, Chih‐Yi Liao, Namrata Anand, Mingyang Li, Sarah Martin, Samantha Orozco
article en

Abstract

Background Biliary tract cancers (BTCs) represent a heterogeneous and aggressive group of malignancies that arise from the biliary epithelial tree. The BTC metastatic state remains a very refractory state, and circulating tumor cells (CTC) can offer a window into the metastatic cascade. We applied a profiling method to understand CTC dynamics for patients with advanced stage BTCs receiving systemic therapy. Methods This was a prospective pilot study that included 15 patients with unresectable or metastatic BTCs receiving systemic therapy. CTCs were purified using a commercially available size-based method and enumerated using immunofluorescent staining for epithelial markers. CTC dynamics were benchmarked against conventional blood biomarkers and correlated with survival outcomes. Results We detected CTCs in every patient sample. CTC quantities did not decline during the early on-treatment time point and were correlated weakly with serum carbohydrate antigen 19–9 level and circulating tumor DNA median variant allele frequency. There was no significant correlation between baseline CTC quantities and progression-free or overall survival. Conclusions Our novel workflow, utilizing a commercially available CTC purification and enumeration process, enabled a sensitive method to quantitatively and serially monitor CTC abundance in a pilot study of patients with BTCs. Future studies will expand upon numbers of participants and the means to detect and characterize these rare metastatic precursor cells in patients with BTCs.

Frontiers in OncologyVol. 16
University of Chicago (US)
Good health and well-being
Cholangiocarcinoma and Gallbladder Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon